Published in Clin Orthop Relat Res on January 28, 1977
Peroneal nerve palsy at the level of the lower third of leg. J R Soc Med (1984) 0.81
An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am (1999) 5.17
Tracheobronchial tree: expandable metallic stents used in experimental and clinical applications. Work in progress. Radiology (1986) 2.05
Wear patterns on retrieved polyethylene tibial inserts and their relationship to technical considerations during total knee arthroplasty. Clin Orthop Relat Res (1994) 2.04
Structure determination of feline panleukopenia virus empty particles. Proteins (1993) 1.99
Metal release in patients who have had a primary total hip arthroplasty. A prospective, controlled, longitudinal study. J Bone Joint Surg Am (1998) 1.96
CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol (1995) 1.93
A study of lower-limb mechanics during stair-climbing. J Bone Joint Surg Am (1980) 1.89
Structure of a viral procapsid with molecular scaffolding. Nature (1997) 1.85
Release and excretion of metal in patients who have a total hip-replacement component made of titanium-base alloy. J Bone Joint Surg Am (1991) 1.85
Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med (1983) 1.85
A relationship between gait and clinical changes following high tibial osteotomy. J Bone Joint Surg Am (1985) 1.82
The influence of total knee-replacement design on walking and stair-climbing. J Bone Joint Surg Am (1982) 1.78
Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas. Int J Cancer (1984) 1.72
Tensile properties of the human lumbar annulus fibrosus. Acta Orthop Scand (1967) 1.69
Pathophysiology of endotoxin shock in the primate. Am J Obstet Gynecol (1970) 1.65
Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ (1991) 1.65
Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology (2001) 1.61
Quantitation of allograft fibrosis and chronic allograft nephropathy. Pediatr Transplant (1999) 1.60
Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol (1998) 1.54
Local and distant products from modularity. Clin Orthop Relat Res (1995) 1.52
Walking speed as a basis for normal and abnormal gait measurements. J Biomech (1977) 1.44
Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood (1984) 1.44
Migration of corrosion products from modular hip prostheses. Particle microanalysis and histopathological findings. J Bone Joint Surg Am (1994) 1.44
Unicompartmental knee arthroplasty. Clinical experience at 6- to 10-year followup. Clin Orthop Relat Res (1999) 1.42
Effect of pegs and screws on bone ingrowth in cementless total knee arthroplasty. Clin Orthop Relat Res (1994) 1.41
In vivo comparative wear study of traditional and highly cross-linked polyethylene in total hip arthroplasty. J Arthroplasty (2005) 1.41
Metal ion release from titanium-based prosthetic segmental replacements of long bones in baboons: a long-term study. J Orthop Res (1984) 1.39
Diffusing capacity limitations of the extent of lung volume reduction surgery in an animal model of emphysema. J Thorac Cardiovasc Surg (1999) 1.39
The structure of human parvovirus B19 at 8 A resolution. Virology (1994) 1.38
Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb (1993) 1.38
Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J (1980) 1.37
Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood (1993) 1.35
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem (1986) 1.33
Endosteal erosion in association with stable uncemented femoral components. J Bone Joint Surg Am (1990) 1.31
Determinants of stress shielding: design versus materials versus interface. Clin Orthop Relat Res (1992) 1.31
Primary total hip reconstruction with a titanium fiber-coated prosthesis inserted without cement. J Bone Joint Surg Am (1993) 1.30
Analog studies of forces in the human spine: mechanical properties and motion segment behavior. J Biomech (1973) 1.29
Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood (1987) 1.29
The influence of walking mechanics and time on the results of proximal tibial osteotomy. J Bone Joint Surg Am (1990) 1.27
Primary total hip arthroplasty using noncemented porous-coated femoral components in patients with osteonecrosis of the femoral head. J Arthroplasty (1994) 1.26
Knee biomechanics and total knee replacement. J Arthroplasty (1986) 1.26
Structural analysis of the Spiroplasma virus, SpV4: implications for evolutionary variation to obtain host diversity among the Microviridae. Structure (1998) 1.24
Tissue plasminogen activator: chemical and physiological aspects. Semin Thromb Hemost (1984) 1.23
Bone resorption activity of particulate-stimulated macrophages. J Bone Miner Res (1993) 1.22
Macrophage/particle interactions: effect of size, composition and surface area. J Biomed Mater Res (1994) 1.22
Second-generation cementless total hip arthroplasty. Eight to eleven-year results. J Bone Joint Surg Am (2001) 1.20
Structure of the Maize streak virus geminate particle. Virology (2001) 1.20
Necrosis of skin induced by coumarin in a patient deficient in protein S. BMJ (1989) 1.20
Failed femoral stems in total hip prostheses. A report of six cases. J Bone Joint Surg Am (1975) 1.19
[Incidence of intramural digestive system hematoma in anticoagulation. Epidemiologic study and clinical aspects of 59 cases observed in Switzerland (1970-1975)]. Schweiz Med Wochenschr (1983) 1.19
Biochemical and physical characterization of parvovirus minute virus of mice virus-like particles. Virology (2000) 1.18
Coeliac disease and diabetes mellitus: a study of 24 patients with HLA typing. Q J Med (1982) 1.17
Long-term followup of the Miller-Galante total knee replacement. Clin Orthop Relat Res (2001) 1.17
Association between histocompatability antigens (HLA) and nasal carriage of Staphylococcus aureus. J Med Microbiol (1983) 1.16
Structural and kinetic analysis of the chemical rescue of the proton transfer function of carbonic anhydrase II. Biochemistry (2001) 1.14
The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Joint Surg Am (2001) 1.13
Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost (1989) 1.12
Fixation, polyethylene wear, and pelvic osteolysis in primary total hip replacement. Clin Orthop Relat Res (1999) 1.12
Cementless acetabular reconstruction after acetabular fracture. J Bone Joint Surg Am (2001) 1.11
Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol (1995) 1.11
Composition and morphology of wear debris in failed uncemented total hip replacement. J Bone Joint Surg Br (1994) 1.11
Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer (1998) 1.11
Defects in failed stems of hip prostheses. J Biomed Mater Res (1978) 1.10
Green fluorescent protein as a novel tool to measure apoptosis and necrosis. Cytometry (2001) 1.10
Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer (1986) 1.10
Revision total knee arthroplasty with a cemented posterior-stabilized or constrained condylar prosthesis: a minimum 3-year and average 5-year follow-up study. J Arthroplasty (1997) 1.09
ESB Research Award 1992. The mechanism of bone remodeling and resorption around press-fitted THA stems. J Biomech (1993) 1.09
Wear in total hip prostheses. An experimental evaluation of candidate materials. Acta Orthop Scand Suppl (1973) 1.08
Family and population studies of HLA and coeliac disease in the West of Ireland. Tissue Antigens (1983) 1.08
Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost (1999) 1.08
Gait compensations in patients with osteoarthritis of the hip and their relationship to pain and passive hip motion. J Orthop Res (1997) 1.08
Segmental replacement of long bones in baboons using a fiber titanium implant. J Bone Joint Surg Am (1978) 1.07
A stress analysis of the femoral stem in total hip prostheses. J Bone Joint Surg Am (1976) 1.07
Problems with cementless total knee arthroplasty at 11 years followup. Clin Orthop Relat Res (2001) 1.06
Causes of fractures of the femoral component in total hip replacement. J Bone Joint Surg Am (1980) 1.05
Changes in the gait patterns of growing children. J Bone Joint Surg Am (1981) 1.05
Retention of the posterior cruciate in total knee arthroplasty. J Arthroplasty (1988) 1.05
Metal release and excretion from cementless titanium alloy total knee replacements. Clin Orthop Relat Res (1999) 1.04
Functional adaptation and ingrowth of bone vary as a function of hip implant stiffness. J Biomech (1998) 1.04
Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase. J Clin Invest (1982) 1.04
Thromboembolic disease in patients undergoing total knee replacement. J Bone Joint Surg Am (1976) 1.03
A quantitative study of bone and soft tissues in cementless porous-coated acetabular components retrieved at autopsy. J Arthroplasty (1993) 1.03
Revision, without cement, of aseptically loose, cemented total hip prostheses. Quantitative comparison of the effects of four types of medullary treatment on bone ingrowth in a canine model. J Bone Joint Surg Am (1993) 1.03
Identification of aleutian mink disease parvovirus capsid sequences mediating antibody-dependent enhancement of infection, virus neutralization, and immune complex formation. J Virol (2001) 1.03
Primary cementless acetabular reconstruction in patients younger than 50 years old. 7- to 11-year results. Clin Orthop Relat Res (1997) 1.02
Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. J Am Soc Nephrol (1998) 1.01
Human monocyte response to particulate biomaterials generated in vivo and in vitro. J Orthop Res (1995) 1.01
The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation. J Thorac Cardiovasc Surg (1975) 1.00
Spondylolisthesis and tight hamstrings. J Bone Joint Surg Am (1970) 1.00
Primary total hip arthroplasty with a porous-coated acetabular component. Seven-to-ten-year results. J Bone Joint Surg Am (1997) 0.99
The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase. Thromb Haemost (1986) 0.98
Anthracene-9,10-diones as potential anticancer agents. Synthesis, DNA-binding, and biological studies on a series of 2,6-disubstituted derivatives. J Med Chem (1992) 0.98
Adaptive bone remodeling around bonded noncemented total hip arthroplasty: a comparison between animal experiments and computer simulation. J Orthop Res (1993) 0.97
Finite element stress analysis of an intervertebral disc. J Biomech (1974) 0.97